Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 23% ± 3% | |
astrocyte | 4 studies | 20% ± 3% | |
glutamatergic neuron | 4 studies | 39% ± 15% | |
oligodendrocyte | 4 studies | 17% ± 1% | |
endothelial cell | 3 studies | 19% ± 4% | |
GABAergic neuron | 3 studies | 36% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 33% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 1523.29 | 21 / 21 | 100% | 20.13 | 504 / 504 |
breast | 100% | 1504.66 | 459 / 459 | 100% | 25.32 | 1118 / 1118 |
liver | 100% | 667.14 | 226 / 226 | 100% | 11.26 | 406 / 406 |
prostate | 100% | 1346.34 | 245 / 245 | 100% | 19.56 | 502 / 502 |
stomach | 100% | 1031.21 | 359 / 359 | 100% | 19.11 | 286 / 286 |
thymus | 100% | 1242.88 | 653 / 653 | 100% | 21.38 | 605 / 605 |
uterus | 100% | 1401.82 | 170 / 170 | 100% | 21.06 | 459 / 459 |
brain | 100% | 1233.53 | 2641 / 2642 | 100% | 26.59 | 705 / 705 |
lung | 100% | 1197.58 | 577 / 578 | 100% | 20.53 | 1155 / 1155 |
intestine | 100% | 1461.13 | 966 / 966 | 100% | 19.49 | 526 / 527 |
kidney | 100% | 969.43 | 89 / 89 | 100% | 17.59 | 899 / 901 |
ovary | 100% | 1302.62 | 180 / 180 | 100% | 17.78 | 429 / 430 |
skin | 100% | 1784.20 | 1809 / 1809 | 100% | 21.07 | 470 / 472 |
adrenal gland | 100% | 1521.66 | 258 / 258 | 100% | 19.65 | 229 / 230 |
esophagus | 100% | 1374.79 | 1445 / 1445 | 99% | 18.87 | 182 / 183 |
pancreas | 99% | 691.65 | 326 / 328 | 99% | 17.15 | 177 / 178 |
adipose | 100% | 1477.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1474.14 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.38 | 29 / 29 |
muscle | 100% | 1732.20 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1274.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.75 | 1 / 1 |
peripheral blood | 98% | 1200.72 | 913 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 777.93 | 844 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 14.24 | 78 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0016567 | Biological process | protein ubiquitination |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0000165 | Biological process | MAPK cascade |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0008139 | Molecular function | nuclear localization sequence binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | BRAP |
Protein name | BRCA1 associated protein BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63) |
Synonyms | RNF52 |
Description | FUNCTION: Negatively regulates MAP kinase activation by limiting the formation of Raf/MEK complexes probably by inactivation of the KSR1 scaffold protein. Also acts as a Ras responsive E3 ubiquitin ligase that, on activation of Ras, is modified by auto-polyubiquitination resulting in the release of inhibition of Raf/MEK complex formation. May also act as a cytoplasmic retention protein with a role in regulating nuclear transport. . |
Accessions | ENST00000327551.6 J3KNN7 Q7Z569 ENST00000419234.9 [Q7Z569-1] |